Cellectis amends follow-on

Cellectis S.A.(Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-03-18 Type: Follow-on To be raised: Up to $148.2 million Shares: 3.5 million Price Prior: EUR12...